4,706 reports of this reaction
4.1% of all VANCOMYCIN HYDROCHLORIDE reports
#2 most reported adverse reaction
ACUTE KIDNEY INJURY is the #2 most commonly reported adverse reaction for VANCOMYCIN HYDROCHLORIDE, manufactured by Hikma Pharmaceuticals USA Inc.. There are 4,706 FDA adverse event reports linking VANCOMYCIN HYDROCHLORIDE to ACUTE KIDNEY INJURY. This represents approximately 4.1% of all 116,197 adverse event reports for this drug.
VANCOMYCIN HYDROCHLORIDE has an overall safety score of 88 out of 100. Patients taking VANCOMYCIN HYDROCHLORIDE who experience acute kidney injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACUTE KIDNEY INJURY is moderately reported among VANCOMYCIN HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to acute kidney injury, the following adverse reactions have been reported for VANCOMYCIN HYDROCHLORIDE:
The following drugs have also been linked to acute kidney injury in FDA adverse event reports:
ACUTE KIDNEY INJURY has been reported as an adverse event in 4,706 FDA reports for VANCOMYCIN HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACUTE KIDNEY INJURY accounts for approximately 4.1% of all adverse event reports for VANCOMYCIN HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience acute kidney injury while taking VANCOMYCIN HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.